HomeNewsBusinessCompaniesThe Jet Airways story: How the airline that brought 'joy to flying' got grounded on April 17, 2019

The Jet Airways story: How the airline that brought 'joy to flying' got grounded on April 17, 2019

Naresh Goyal did a lot of things right in creating a world-class airline. Alas, he also committed a few errors

October 17, 2020 / 17:50 IST
Story continues below Advertisement

The story, first published in April 2020, has been updated after it was announced on October 17, that the Kalrock Capital-Murari Jalan combine has won the bid for Jet Airways

Amritesh Singh* is glad he is not a pilot. Technically he may be one, but 10 years ago when getting a pilot's job became tough, Singh re-skilled himself and got a 'ground' job. One solace for the aviation lover was that he landed a job at Jet Airways, then the country's largest airline.

Story continues below Advertisement

"I spent 10 years in the company. It was a great time. We were at the forefront, when it came to industry practices," says Singh.

But his tone changes when asked about the days leading to April 17, 2019, when Jet Airways suspended its operations. "It became difficult. When close friends or relatives would ask if they should book or not, I wouldn't know what to say," recounts Singh, who joined a non-airline company in May.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show